Omnicell, Inc. (OMCL Quick QuoteOMCL - Free Report) was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $68.61 –$92.21 in the past one-month time frame, witnessed a sharp increase yesterday.

The stock gained following news that Northern Arizona Healthcare has inked a 10-year, source agreement with the company, leveraging Omnicell’s industry-leading automation solutions.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Omnicell currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Omnicell, Inc. Price

Investors interested in the Medical Info Systems industry may consider Cerner Corporation , which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is OMCL going up? Or down? Predict to see what others think:Up or Down

Radical New Technology Creates $12.3 Trillion Opportunity

Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.

Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.

See the 7 breakthrough stocks now>>